|
ABCD4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.765200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.664400E-01 |
| Normal-vs-Stage2 |
3.563600E-01 |
| Normal-vs-Stage3 |
3.090200E-01 |
| Normal-vs-Stage4 |
1.614950E-01 |
| Stage1-vs-Stage2 |
7.614600E-01 |
| Stage1-vs-Stage3 |
3.904300E-02 |
| Stage1-vs-Stage4 |
3.015700E-02 |
| Stage2-vs-Stage3 |
1.133010E-01 |
| Stage2-vs-Stage4 |
6.448200E-02 |
| Stage3-vs-Stage4 |
6.128400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.352800E-01 |
| Normal-vs-AfricanAmerican |
2.003000E-01 |
| Normal-vs-Asian |
5.466500E-02 |
| Caucasian-vs-AfricanAmerican |
1.182560E-01 |
| Caucasian-vs-Asian |
1.351020E-01 |
| AfricanAmerican-vs-Asian |
1.607860E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.429400E-01 |
| Normal-vs-Female |
9.393800E-01 |
| Male-vs-Female |
5.096600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.161960E-01 |
| Normal-vs-Age(41-60Yrs) |
8.659800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.604800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.391600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.476420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.387590E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.402200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.910400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.253440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.345800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.11469999997116E-06 |
| Classical-VS-Follicular |
1.879040E-01 |
| Classical-VS-Other |
8.438000E-01 |
| Classical-VS-Normal |
1.890600E-01 |
| Tall-VS-Follicular |
8.284700E-03 |
| Tall-VS-Other |
1.560790E-01 |
| Tall-VS-Normal |
3.226100E-04 |
| Follicular-VS-Other |
5.751000E-01 |
| Follicular-VS-Normal |
7.239000E-01 |
| Other-VS-Normal |
6.641400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.601210E-01 |
| Normal-vs-N1 |
1.141560E-01 |
| N0-vs-N1 |
7.619000E-03 |
|
|
